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mononucleosis is accompanied by an absolute lymphocyto-
sis, usually with more than 20% atypical lymphocytes.
Most of these are monoclonal or oligoclonal activated
CD8+ cells specific for EBV antigens [3]. Neutropenia, es-
pecially in young children, is relatively common [4, 5]. In
patients with different types of congenital, acquired or ia-
trogenic immune deficiency, the response to EBV infection
may be inadequate resulting in uncontrolled proliferation of
virus-containing cells [6–9]. Liver disease is present in al-
most all affected cases, causing death in about half of the
patients [10]. Since these fatal EBV infections in previous-
ly healthy children are rare, very few data exist concerning
lymphocyte subpopulations in the peripheral blood [11, 12].
We describe a 10-year-old boy with fatal EBV-associated
infectious mononucleosis, who showed a population of
atypical CD3+ CD4low but CD8– cells in his peripheral
blood.
Case Report
A previously healthy 10-year-old boy born to nonconsanguineous
Greek parents developed a morbiliform exanthema, fever, jaundice
and hepatosplenomegaly, without enlarged lymph nodes, 10 days af-
ter treatment with amoxicillin. At that time EBV IgG ELISA titres
were extremely high (92,000 U/l). Three months after disease onset,
liver function tests were still abnormal. Acute infectious hepatitis
(hepatitis A, hepatitis B and hepatitis C virus, human immunodefi-
ciency virus, leptospirosis, herpes simplex virus, cytomegalovirus,
EBV IgM were negative) and metabolic diseases (Æ1-antitrypsin defi-
ciency, Wilson’s disease) were excluded and the boy was transferred
for liver biopsy. Laboratory tests revealed elevated liver enzymes
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Abstract
A previously healthy 10-year-old Greek boy born to non-
consanguineous healthy parents developed progressive
liver disease after acute infectious mononucleosis. EBV-
induced autoimmune hepatitis was suspected and treat-
ment was started with high-dose prednisolone, acy-
clovir and intravenous immunoglobulins. Despite
therapy, his liver function continuously deteriorated and
the child died 9 months later in profound immune defi-
ciency from candida septicemia. Flow cytometric analy-
sis of his lymphocytes revealed a major subpopulation
of atypical cells (20.3%) which were CD3+, fitted into the
lymphocyte gate but showed a very low level of CD4 ex-
pression, comparable to that of monocytes. After short-
time cell culture, the cells became adherent and devel-
oped granules and dendrites. We conclude that these
cells may represent strongly activated CD4+ T lympho-
cytes with downregulated CD4 expression or a subtype
of dendritic cells.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
F 1999 S.Karger AG, Basel
1018–2438/99/1181–0074 $17.50/0
Accessible online at:
http://BioMedNet.com/karger
Correspondence to: Dr. med. Rudolf Gruber
Medizinische Poliklinik
Pettenkoferstrasse 8a, D–80336 München (Germany)
Tel. +89 5160 3347, Fax +89 5160 4439
E-Mail Rudolf.Gruber@pk-i.med.uni-muenchen.de
Introduction
Infectious mononucleosis is a common self-limiting dis-
ease of children and young adults caused by Epstein-Barr
virus (EBV). The main clinical and laboratory features are
fever, lymphadenopathy and pharyngitis. In about 50% of
patients, hepatosplenomegaly occurs with elevated trans-
aminases and occasionally jaundice [1, 2]. Acute infectious
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(alanine aminotransferase 417 U/l, aspartate aminotransferase 304
U/l) and conjugated hyperbilirubinemia (6.4 mg/dl), signs of hemoly-
sis, elevated IgG (22 g/l) and low positive titers (1:40) of antinuclear
and anti-smooth muscle antibodies. Repeated testing for EBV con-
firmed negative EBV-VCA IgM, positive EBV-VCA IgG (1:1,024),
EBV-EA IgG (1:64) and negative anti-EBNA IgG. Liver biopsy
showed intralobular hepatitis and mild periportal lymphocyte cell in-
filtration consisting mainly of CD3+ T cells. Immunohistochemistry
was negative for EBV, cytomegalovirus and herpes simplex virus 
type 1. Autoimmune-type hepatitis was suspected, and treatment with
prednisolone (60 mg/day) was started. After transient improvement,
liver function tests deteriorated. Since replicating EBV DNA was
demonstrated in whole blood, serum, sputum and bone marrow by
PCR, high-dose intravenous immunoglobulin, acyclovir and later
ganciclovir were added. Liver enzymes further increased (20–100
times upper limit of normal) and EBV PCR remained positive in
serum throughout therapy; however, liver biopsies 2 and 4 months af-
ter initiating the therapy did not reveal EBV by different methods.
One year after onset of liver disease, the boy developed liver failure,
interstitial pneumonitis and severe neutropenia and died from candida
septicemia. Autopsy was not done.
Materials and Methods
Flow Cytometric Analysis of Peripheral Blood Cells
Flow cytometric analysis was performed as previously described
[13]. In brief , 90 íl EDTA blood were incubated at room temperature
for 10 min with 10 íl of a combination of three directly conjugated
monoclonal antibodies: CD3–, CD45RO-FITC (Coulter, Krefeld,
Germany), CD25-, CD57-, ç/ä-TCR-FITC (Becton Dickinson, Hei-
delberg, Germany), CD4-, CD16-, CD56-, CD69-, HLA-DR-PE
(Becton Dickinson), CD14-, CD19-, CD8-Tricolor® (Medac, Ham-
burg, Germany) in optimal dilutions. Blood was lysed in a Q-Prep
lysing apparatus (Coulter) and analyzed by flow cytometry within 
24 h (FACScan, PAINT-a-GATE data analysis program, Becton 
Dickinson). For the analysis of subpopulations, gates were set on lym-
phocytes, monocytes, or lymphocytes and monocytes, respectively.
Cell Culture Assays
Short-time cell culture was performed with peripheral blood
mononuclear cells (PBMC) isolated from heparinized blood by den-
sity centrifugation over Ficoll-Hypaque (Pharmacia, Uppsala, Swe-
den). The cells were cultured in 96-well culture plates (NUNC, Wies-
baden, Germany) at 37°C in RPMI medium (Gibco, Eggenstein,
Germany), supplemented with L-glutamine, penicillin/streptomycin
and 10% human AB serum. Atypical CD4low cells were enriched by 
1 h incubation of PBMCs in culture flasks to remove monocytes by
adhesion. The nonadherent cells were cultured in 96-well culture
plates.
Results
Flow Cytometry
Flow cytometric analysis of the boy’s peripheral blood
cells revealed a major subpopulation (20.3%) of atypical
cells in the lymphocyte gate. These cells were CD3+; but
the level of CD4 expression was very low, comparable to
that of monocytes. They were HLA-DR+ and CD45RO+,
but CD8–, CD14–, CD19–, CD16–, CD56–, CD57–,
CD25– and ç/ä-TCR—. The remaining PBMC consisted of
19.9% monocytes with regular FSC/SSC characteristics,
7.5% ‘normal’ CD4high T cells, 29% CD8+ T cells, 10% B
cells and 9.3% NK cells (fig. 1). The flow cytometric anal-
ysis was repeated 4 weeks later with no significant change
in any cell population.
Cell Culture
Using whole PBMCs for cell culture, ‘clusters’ of differ-
ent cells could be seen for about 20 days, but then disinte-
grated (fig. 2A). After 24 h in culture, isolated atypical
CD4low lymphocytes became adherent, enlarged and ac-
quired multiple granules and dendrites (fig. 2B). When re-
moving the cells from the culture dishes, all cells disinte-
grated. Analysis in 96-well microtiter plates showed a loss
of CD3 and CD4. The cells remained negative for CD8 and
CD14, but stained brightly for HLA-DR. No cell line of
these atypical CD4low lymphocytes could be maintained.
Discussion
Fatal infectious mononucleosis occurs as an X-linked
lymphoproliferative syndrome (XLP) in males [11, 14, 15].
In addition, Sakamoto et al. [16] and others described a spo-
radic form of fatal mononucleosis in previously healthy
males and females. The median age at death of patients with
sporadic fatal mononucleosis is about 10 years, in contrast
to only 2.5 years in children dying from XLP [10]. Our pa-
tient died at the age of 10 years, 1 year after acute infectious
mononucleosis from EBV-induced immunodeficiency with
severe liver and pulmonary disease. The patient had no sib-
lings and the family history was negative for fatal infections
or deaths of unknown cause during childhood. Bone mar-
row aspiration showed no signs of a hemophagocytic syn-
drome. Sonography and CT scan did not reveal any devel-
opment of lymphoma. Serology showed persistently high
titers of EBV-VCA-IgG and EBV-EA-IgG. EBV DNA was
detected by PCR in whole blood, serum, sputum and bone
marrow. EBV-VCA IgM was negative, but a false-negative
result at the onset of disease due to the presence of exceed-
ingly high titers of EBV-VCA IgG masking IgM cannot be
excluded. Throughout the whole course of disease, anti-
EBNA remained negative, thus indicating chronic EBV in-
fection without adequate immune response. Therefore, we
suspect that our patient represents one of the sporadic cases
of fatal chronic EBV infection. Hepatopathy was the pre-
Fig. 1. Flow cytometric analysis of peripheral blood cells. A,B Gate set on lymphocytes and monocytes. A FSC/SSC
characteristics of the PBMCs. B Gated mononuclear cells: monocytes (blue), typically low CD4low+. Two populations
of CD3+ cells: green normal CD4high T lymphocytes, red atypical CD4low+ cells. C–F Gate on lymphocytes. Expres-
sion of CD45RO (C), expression of CD69 on most atypical cells (D), HLA-DR (F) on virtually all atypical cells, but
no expression of CD25 on these cells (E).
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Fig. 2. A Short-time cell culture of isolated
PBMC: ‘clusters’ of different cells which
could be seen for about 20 days but then dis-
integrated. E 220. B Enriched atypical
CD4low cells: within 48 h, the cells became
adherent and developed granules and small
dendrites (–c). E360.
senting manifestation of the boy as has been described in
the literature for most similar cases [10]. A direct hepatocy-
topathic effect of the virus has been suggested [17]. How-
ever, the only proven receptor for EBV (CD21 or C3d) is
confined to B cells, T cells and dendritic reticulum cells, al-
though for certain anti-CD21 antibodies, a staining on dif-
ferent other cells, including hepatocytes was found [18].
Vento et al. [19] suggested that EBV triggers an autoim-
mune reaction directed against hepatocytes in susceptible
persons. This concept is supported in our patient by the ab-
sence of virus DNA in all three liver biopsies, whereas EBV
DNA could be seen in sputum, peripheral blood and bone
marrow.
There are only few data describing alterations in the
lymphocyte subpopulations of peripheral blood of patients
with chronic EBV infection. One case report described an
EBV-induced CD30+ NK cell-type malignancy. Interest-
ingly, this patient also had a remarkable hypogammaglobu-
linemia. The atypical cells in our patient were negative for
NK-cell markers such as CD16, CD56 and CD57 [20].
Three cases of XLP described by Sullivan and Woda [11]
showed largely increased CD8 T cells, increased B cells but
diminished CD4 T cells. Further, the amount of CD4 ex-
pressed at the cell surface is very restricted in vivo. Thus,
even in HIV infection, CD4 expression on T cells in periph-
eral blood remains high [6]. A rare exception is the descrip-
tion of CD4low, CD8+ HLA-DR+ lymphocytes in patients
with acute infectious mononucleosis [12]. In vitro, CD4 can
be downregulated by strong activation, e.g. with phorbol
myristate acetate (PMA) or anti-CD3 antibodies [21, 22].
A
B
Therefore the downregulation of CD4 in our patient may be
due to a specific activation by EBV or an indirect activation
of the immune system. This is supported by the expression
of other markers of activation on these cells. Sixty percent
of the cells were positive for CD69, a marker which is ex-
pressed in the early phase of lymphocyte activation. In ad-
dition, all cells were positive for HLA-DR, which is usual-
ly expressed in a later phase of activation. Recent work
indicates that cells of the T cell lineage can be infected with
EBV via a CD21-like molecule [23, 24]. However, altered
CD4 expression has not been described in EBV-infected T
cells. In peripheral blood, monocytes and dendritic cells al-
so show a low expression of CD4. Some features give evi-
dence that these cells may be related to dendritic cells: low
expression of CD4, high positivity for HLA-DR, but no
CD14 expression. They fit perfectly into the lymphocyte
gate, but adhere to plastic dishes and establish tiny dendrites
after long-term in vitro culture. On the other hand, these
cells strongly express CD3, which is not found on dendritic
cells [26] (fig. 1). However, since most methods to isolate
dendritic cells use a T cell depletion step, e.g. with mono-
clonal anti-CD3 antibodies, CD3+ dendritic cells may be
lost for analysis. We cannot exclude the possibility that
these CD3+, CD4low cells were induced by therapy with
acyclovir or ganciclovir although such effects have not been
reported. It seems unlikely that these cells represent true
neoplasms because EBV-induced leukemia or lymphoma
were excluded by bone marrow aspiration and CT scan. In
summary, we suggest, that the CD3+, CD4low cells of the
patient represent either strongly activated T cells with
downregulated CD4 expression or a hitherto unknown sub-
type of dentritic cells.
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